Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Despite an initial 80% response rate, the 5-year survival rate is only 15% as most patients develop recurrence. In the recurrent setting, co-presentation with micrometastasis and chemoresistance limits the value of available treatment options. Therefore, to improve survival it is critical to understand the mechanisms that promote recurrence and metastasis and to develop novel approaches to prevent it. To achieve this, elucidation of the cellular origin and regulatory processes governing metastasis is a requisite. We propose that in EOC, metastatic potential is limited to a subfraction of cancer cells with inherent plasticity, stemness, and a mesenchymal/migratory phenotype: the mesenchymal cancer stem cells (mCSCs). We show evidence that mCSCs originate from EOC stem cells and that its generation is strongly driven by the TGF/Twist1 axis independent of the classical TGF/Smad pathway. Therefore, our central hypothesis is that specific targeting and controlled release of TGF? inhibitors in the tumor microenvironment will potently block the TGF/Twist1 pathway to prevent the formation of mCSCs and decrease metastatic tumor burden. We have developed a nanoscale liposomal polymeric gel (nLGs) platform coated with the RGD peptide (Arg-Gly-Asp), which targets the cellular adhesion molecule, av3 integrins that are highly expressed in tumor-associated neovasculature. Importantly, in addition to conferring specificity, the proposed nLG delivery platform also provides a synergistic two-prong approach for TGF? inhibition.
Our specific aims are:
Aim 1. To determine the role of TGF /PKC pathway in Twist1 stabilization and generation of mesenchymal/migratory ovarian cancer stem cells;
Aim 2. Characterization of tumor neovasculature-targeted delivery system for simultaneous inhibition of TGF processing and secretion for prevention of metastasis;
Aim 3. To determine the efficacy of av3-directed nanoparticle with encapsulated TGF inhibitor in an EOC in vivo model. Upon completion of these studies, we will have a better understanding of the initiation and establishment of metastatic disease in EOC and we will provide a novel therapeutic approach to decrease metastatic tumor burden using a safe and promising particulate delivery platform. With this new perspective, we will be able to create a better plan of management to decrease metastatic load and improve patient survival in this lethal gynecologic malignancy.

Public Health Relevance

Findings from this study may aid in better understanding of the initiation and establishment of metastatic disease in ovarian cancer. Furthermore, we will provide a novel nanoparticle-based targeted delivery system to decrease metastatic tumor burden.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA199004-04
Application #
9515910
Study Section
Developmental Therapeutics Study Section (DT)
Program Officer
Chen, Weiwei
Project Start
2015-07-06
Project End
2020-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Yale University
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Alvero, Ayesha B; Kim, Dongin; Lima, Eydis et al. (2017) Novel approach for the detection of intraperitoneal micrometastasis using an ovarian cancer mouse model. Sci Rep 7:40989
Cardenas, Carlos; Montagna, Michele K; Pitruzzello, Mary et al. (2017) Adipocyte microenvironment promotes Bclxlexpression and confers chemoresistance in ovarian cancer cells. Apoptosis 22:558-569
Siefert, Alyssa L; Caplan, Michael J; Fahmy, Tarek M (2016) Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy. Biomaterials 97:85-96
Cardenas, Carlos; Alvero, Ayesha B; Yun, Bo Seong et al. (2016) Redefining the origin and evolution of ovarian cancer: a hormonal connection. Endocr Relat Cancer 23:R411-22
Labowsky, Michael; Lowenthal, Justin; Fahmy, Tarek M (2015) An in silico analysis of nanoparticle/cell diffusive transfer: application to nano-artificial antigen-presenting cell:T-cell interaction. Nanomedicine 11:1019-28
Sehgal, Kartik; Ragheb, Ragy; Fahmy, Tarek M et al. (2014) Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk. J Immunol 193:2297-305